Tyra Biosciences, Inc.
TYRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $92 | $58 | $251 | $302 |
| Short-Term Investments | $249 | $145 | $0 | $0 |
| Receivables | $2 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $8 | $6 | $2 |
| Total Curr. Assets | $347 | $212 | $257 | $304 |
| Property Plant & Equip (Net) | $8 | $8 | $4 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $8 | $6 | $5 | $1 |
| Total NC Assets | $16 | $14 | $9 | $3 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $364 | $226 | $266 | $307 |
| Liabilities | – | – | – | – |
| Payables | $1 | $5 | $1 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $14 | $10 | $4 | $3 |
| Total Curr. Liab. | $15 | $15 | $6 | $4 |
| LT Debt | $6 | $6 | $2 | $1 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $6 | $6 | $3 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $6 | $6 | $3 | $1 |
| Total Liabilities | $20 | $22 | $8 | $5 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$251 | -$165 | -$96 | -$40 |
| AOCI | $1 | $0 | $0 | $0 |
| Other Equity | $594 | $369 | $354 | $342 |
| Total Equity | $343 | $204 | $258 | $302 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $364 | $226 | $266 | $307 |
| Net Debt | -$86 | -$52 | -$249 | -$301 |